XORTX Therapeutics Inc. announce the appointment of Jacqueline Le Saux to the Company’s board of directors and the resignation of Allan Williams. Ms. Le Saux is a seasoned Canadian health care legal executive who has held senior positions at large and small public and private life science companies. Jacqueline’s legal experience is focused on securities, pharmaceutical regulatory and intellectual property law.